PROPANC BIOPHARMA, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.1M | $13.1K | $2.3K |
| FY2022 | $3.1M | $81.7K | $4.1K |
| FY2023 | $3.2M | $60.3K | — |
| FY2024 | $3.9M | $72.4K | — |
| FY2025 | $5.7M | $19.6M | — |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.1M | $13.1K | $2.3K |
| FY2022 | $3.1M | $81.7K | $4.1K |
| FY2023 | $3.2M | $60.3K | — |
| FY2024 | $3.9M | $72.4K | — |
| FY2025 | $5.7M | $19.6M | — |